Results 211 to 220 of about 22,457 (246)

SphK1 Suppresses Human Dental Pulp Stem Cell Apoptosis by Promoting Glycolysis Under Simulated Microgravity. [PDF]

J Tissue Eng Regen Med
Che J, Qiu Z, Hou H, Li Y, He L, Sun J, Zhang S, Li M, Pan S, Zhang W, Niu Y.   +10 more
europepmc   +1 more source

RETRACTION: Downregulation of the Proton-Activated Cl- Channel TMEM206 Inhibits Malignant Properties of Human Osteosarcoma Cells. [PDF]

Oxid Med Cell Longev
Cellular Longevity OMA.
europepmc   +1 more source

BRG1 inhibits glycolysis by promoting SHP1-mediated dephosphorylation of PKM2 in non-small cell lung cancer. [PDF]

Oncogenesis
Zhan W, Zhang H, She X, Zhang G, Zhang J, Luo X, Li H, Lan J.   +7 more
europepmc   +1 more source

Manipulation of glucose and hydroperoxide metabolism to improve radiation response [PDF]

, 2019
Floberg, John M, Schwarz, Julie K
core   +1 more source

Targeting aerobic glycolysis by quercetin inhibits acute monocytic leukemia SHI-1 cells. [PDF]

Ann Med Surg (Lond)
Liu Y, Lv K, Gao R, Yu X, Ni R, Lan J, Wang B, Zhao Y.   +7 more
europepmc   +1 more source

YOD1 mediates isoproterenol-induced cardiac remodeling by deubiquitinating PKM2 and reducing PKM2 tetramerization in cardiomyocytes

Acta Pharmacologica Sinica
Zheng, Qing-song, Xiong, Yong-qiang, Xu, Jia-chen, Qian, Jin-fu, Luo, Wu, Wang, Qin-yan, Zhao, Yan-ni, Luo, Yue, Cui, Ya-qian, Fang, Yi, Guo, Xiao-chen, Chen, Ding-dao, Wang, Yi, Liang, Guang   +13 more
openaire   +1 more source

PKM2 orchestrates tumor progression via metabolic reprogramming and MDSCs-mediated immune suppression in the tumor microenvironment. [PDF]

Front Immunol
Liu W, Wu J, Zhang X, Zhang Y, Zeng X, Peng X.   +5 more
europepmc   +1 more source

PKM2-driven metabolic reprogramming in digestive system tumors: mechanisms, therapeutic advances, and clinical challenges. [PDF]

Front Immunol
Huang X, He J, Sun H, Wu Y, Gu R, Li Z.
europepmc   +1 more source

Oral delivery of dextran-modified albumin nanoparticles loaded with shikonin for targeted therapy of colorectal cancer. [PDF]

Discov Nano
Ren Z, Zhao J, Li S, Hong Y.
europepmc   +1 more source

Erratum: MiR-374b re-sensitizes hepatocellular carcinoma cells to sorafenib therapy by antagonizing PKM2-mediated glycolysis pathway. [PDF]

Am J Cancer Res
Zhang M, Zhang H, Hong H, Zhang Z.
europepmc   +1 more source